Selank
peptideevidence: emerging · v1.0.0Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, studied in anxiolytic and neurotrophic research models. Lyophilized powder. Reconstitute with bacteriostatic water for in-vitro research. Store at -20°C. Certificate of Analysis attached to this listing.
Modulation of neuropeptide and immune signaling.
Selank works through several brain pathways at once. That is why it can calm anxiety while still leaving thinking sharp, instead of dulling the mind the way many anti-anxiety drugs do.
GABA System GABA is the brain's main slow-down signal. When GABA is active, overexcited brain cells settle. Selank changes how GABA's docking sites work in a way that looks similar to how benzodiazepines act, but without the same sedation or dependence pattern.
Serotonin and Dopamine Selank affects how the brain handles serotonin, dopamine, and norepinephrine. Serotonin shifts help mood. Dopamine and norepinephrine shifts help focus, motivation, and learning.
BDNF (Brain Growth Signal) BDNF is a protein that helps brain cells grow and connect. Intranasal Selank quickly raises BDNF levels in the hippocampus in animal studies. The hippocampus is the brain region most tied to memory.
Enkephalin Stabilization Enkephalins are the body's natural calming molecules, similar in family to endorphins. Selank slows the enzymes that break enkephalins down, so they stay active in the bloodstream longer.
Immune Signaling Selank is built from tuftsin, an immune-related molecule the body makes on its own. So Selank also nudges immune signals like IL-6 and the Th1/Th2 balance. In one Russian study of anxiety patients, those immune markers shifted across a 14-day course. [Source: Peptide Dosing Protocols]
Selank helps reduce anxiety and improve focus by interacting with brain chemicals and pathways, including GABA, serotonin, and dopamine.
Amino sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
COA: View certificate (batch TET-4904-A) →
Teton Labs product catalog · research-use compound data.
- Not for unsupervised human use.
- Not FDA-approved in the United States.
- Selank has a mild safety profile.
- Lower starting doses help find the dose where the calming effect shows up without extra side effects.
- CBC at baseline and week 4
- Russian clinical protocols use a 14-21 day course at 600-2,700 mcg per day, split into 2 or 3 sprays. · Russian clinical reference protocols
- Dr. William Seeds has documented injectable Selank doses of 100-300 mcg per day as appropriate and well tolerated for most subjects. · Seeds/2026
Provider-only reference. This page does not constitute medical advice, a recommendation, or dosing guidance.